Humacyte, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -21.7% | -17.4% | -9.2% |
| FY2022 | -10.2% | -10.2% | -5.9% |
| FY2023 | -817.8% | -212.4% | -86.4% |
| FY2024 | 282.3% | 282.3% | -107.9% |
| FY2025 | -1,313.4% | -105.9% | -35.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -21.7% | -17.4% | -9.2% |
| FY2022 | -10.2% | -10.2% | -5.9% |
| FY2023 | -817.8% | -212.4% | -86.4% |
| FY2024 | 282.3% | 282.3% | -107.9% |
| FY2025 | -1,313.4% | -105.9% | -35.1% |